- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Transfusion-dependent anaemia is a form of anaemia characterized by the need for continuous blood transfusion. It is a condition that results from various diseases and is associated with decreased survival rates.
The most common symptom that occurs is fatigue. Various diseases can lead to transfusion-dependent anaemia, most notably Myelodysplastic syndromes (MDS) and thalassemia.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
TGF-beta |
Fusion protein |
Reblozyl® |
50 mg/mL |
– |
2 mg |
-80°C |
07/2023 |
496,80 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin